Brian Engelhardt
Affiliations: | 2014-2019 | Internal Medicine | Vanderbilt University School of Medicine, Nashville, TN, United States |
Google:
"Brian Engelhardt"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Marvin-Peek J, Mason EF, Kishtagari A, et al. (2023) TP53 mutations are associated with increased infections and reduced hematopoietic cell transplantation rates in myelodysplastic syndrome and acute myeloid leukemia. Transplantation and Cellular Therapy |
| Fraebel J, Engelhardt BG, Kim TK. (2022) Non-infectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy |
| Patel A, Wilkerson K, Chen H, et al. (2022) Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. Transplantation and Cellular Therapy |
| Patel DA, Mendoza KA, Chen H, et al. (2021) Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant. Journal of Hematology. 10: 35-39 |
| Gatwood KS, Day J, Culos KA, et al. (2021) Incidence and Outcomes of Early Fever Following Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide Transplantation and Cellular Therapy. 27: S465-S466 |
| Rao UK, Engelhardt BG. (2020) Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2). Clinical Hematology International. 2: 101-108 |
| Mangan BL, Patel D, Chen H, et al. (2020) New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide. Ejhaem. 1: 576-580 |
| Byrne M, Danielson N, Sengsayadeth S, et al. (2020) The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia. American Journal of Hematology |
| Baskett J, Culos KA, Satyanarayana G, et al. (2020) Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study. Annals of Hematology |
| Patel DA, de la Fuente J, Matheney M, et al. (2020) Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease Blood. 136: 20-20 |